Clinical Trial

Exercise Reset for Concussion in a Military Environment

Recruiting
View on ClinicalTrials.gov →
Summary
Our primary objective is to show that early, personalized aerobic exercise treatment safely improves concussion recovery, speeds RTD, and reduces persistent symptoms in CSM. Our secondary objectives include demonstrating the clinical utility of our March-in-place test and determining fundamental mechanisms for the effect of exercise rehabilitation on concussion recovery. We will conduct a prospective four-year multicenter mechanistic treatment (Phase 3) RCT in CSM of personalized sub-threshold aerobic exercise added to the PRA compared with the PRA alone. Non-concussed, age-matched SM will serve as a healthy control group (HC) for comparing CSM to normal physiology and to control for the effect of time and of aerobic exercise.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-08-09; most recent amendment 2026-01-16.
Status change: Not Yet Recruiting → Recruiting 2024-08-21
Trial Details
NCT Number NCT05498038
Lead Sponsor State University of New York at Buffalo
Collaborators: United States Department of Defense, Children's Hospital of Philadelphia, University of Pennsylvania, University of North Carolina, Chapel Hill, The Geneva Foundation, Center for Neuroscience and Regenerative Medicine (CNRM), Axon Medical Technologies LLC
Conditions Brain Concussion
Enrollment 168 participants
Start Date 2024-08-07
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21